Many Michigan Medicine programs and clinics are multidisciplinary, which means physicians from more than one specialty area work together to provide patient care within the program.
Hereditary Hemorrhagic Telangiectasia (HHT) is not a common disease, and not one that is familiar to most doctors. However, there are number of Michigan Medicine providers who have special experience, interest, and desire to help patients with HHT maintain their health, prevent complications, and treat medical issues as they arise. The program includes evaluation in multiple specialties including otolaryngology (for nosebleeds), pulmonary diseases, interventional radiology, gastroenterology, neurosurgery, liver diseases, cardiology, heart failure, dermatology, radiation oncology, hematology-oncology and associated pediatric subspecialties. Visit our Hereditary Hemorrhagic Telangiectasia (HHT) page for more information about the Michigan Medicine HHT Program.